Intramuscular injection of vectorized-scFvMC1 reduces pathological tau in two different tau transgenic models | Acta Neuropathologica Communications | Full Text

Intramuscular injection of vectorized-scFvMC1 reduces pathological tau in two different tau transgenic models | Acta Neuropathologica Communications | Full Text

Intramuscular injection of vectorized-scFvMC1 reduces pathological tau in two different tau transgenic models

With evidence supporting the prion-like spreading of extracellular tau as a mechanism for the initiation and progression of Alzheimer’s disease (AD), immunotherapy has emerged as a potential disease-modifying ...

Authors:Francesca Vitale, Jasmin Ortolan, Bruce T. Volpe, Philippe Marambaud, Luca Giliberto and Cristina d’Abramo

Citation:Acta Neuropathologica Communications 2020 8:126

Content type:Research

 

Published on: 6 August 2020

• ViewFull Text
 
• ViewPDF